KCM
WVE icon

Kennedy Capital Management’s Wave Life Sciences WVE Stock Holding History

Kennedy Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Sell
429,121
-90,647
-17% -$601K 0.04% 427
2026
Q1 		$3.77M Buy
519,768
+27,331
+6% +$356K 0.08% 341
2025
Q4 		$8.37M Sell
492,437
-48,000
-9% -$488K 0.18% 195
2025
Q3 		$3.96M Buy
540,437
+506,437
+1,490% +$4.1M 0.09% 333
2025
Q2 		$221K Buy
+34,000
New +$225K 0.01% 562

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Kennedy Capital Management's WVE Position: Q2 2026 in Review

Kennedy Capital Management reduced its Wave Life Sciences (WVE) stake by 17% in Q2 2026, selling an estimated $601K and leaving 429,121 shares worth $2.49M. The position accounts for 0.04% of the portfolio, ranked #427.

Kennedy Capital Management first reported a position in WVE in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.37M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Kennedy Capital Management held 429,121 shares of Wave Life Sciences worth $2.49M as of Q2 2026.
  • Kennedy Capital Management sold 90,647 Wave Life Sciences shares in Q2 2026, an estimated $601K.
  • Wave Life Sciences made up 0.04% of Kennedy Capital Management's portfolio in Q2 2026, its #427 holding.
  • Kennedy Capital Management first reported a position in Wave Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Kennedy Capital Management's Wave Life Sciences position peaked at $8.37M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.